Ignite Creation Date:
2025-12-24 @ 11:20 PM
Ignite Modification Date:
2025-12-25 @ 9:02 PM
Study NCT ID:
NCT00447356
Status:
WITHDRAWN
Last Update Posted:
2013-05-13
First Post:
2007-03-12
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
High-Dose Interferon Alfa in Treating Patients With Stage II or StageIII Melanoma
Sponsor:
Hackensack Meridian Health
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2000-01
Start Date Type:
None
Primary Completion Date:
None
Primary Completion Date Type:
None
Completion Date:
None
Completion Date Type:
None
First Submit Date:
2007-03-12
First Submit QC Date:
None
Study First Post Date:
2007-03-14
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2013-05-09
Last Update Post Date:
2013-05-13
Last Update Post Date Type:
ESTIMATED